- Press Contact
- Global Marketing Manager
In an Irish study the researchers investigated the use of TIGR® Matrix long term resorbable mesh in 56 patients undergoing immediate breast reconstructions after mastectomy. The authors concluded that TIGR® Matrix was an effective adjunct for use in breast reconstruction, providing excellent cosmetic outcomes with minimal rates of complications.
A new clinical study evaluating the role of TIGR® Matrix in immediate implant-based breast reconstruction has been published ahead of print by the journal Breast Cancer Management.
IMCAS Annual World Congress is held in Paris during the month of January and welcomes more than 7 000 participants from 85 countries. This year the congress is taking place between 26 January - 29 January at Palais des Congrès , Paris
Novus Scientific main sponsor at Rome Breast Surgery Symposium 2016
2nd day of the EHS meeting in Rotterdam in the Netherlands.
Today, Thursday May 26 starts the Akademikliniken’s 12th International aesthetic medicine meeting in Stockholm. TIGR® Matrix is of course here! http://www.beautythroughscience.com/
Novus Scientific is showcasing TIGR® Matrix at Paris Breast Rendez- vous 2016 together with the French distributor Aspide Medical. Read more about Novus Scientific and TIGR® Matrix at www.tigrmatrix.com Read more about Aspide Medical at : http://www.aspide.com
Novus Scientific (www.novusscientific.com) is an innovator in the development and commercialization of resorbable implants, that is aimed to help the body to heal it self.
Global HQ, R&D and manufacturing is located in Uppsala, Sweden.